Humanwell Healthcare (Group) Co.,Ltd. (SHA:600079)

SHA:600079 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	25,156	25,386	24,445	22,276	20,510	20,598
Other Revenue	49.36	49.36	79.84	61.67	38.69	82.45
Revenue	25,206	25,435	24,525	22,338	20,549	20,680
Revenue Growth (YoY)	2.19%	3.71%	9.79%	8.71%	-0.63%	-5.17%
Cost of Revenue	13,868	14,123	13,302	12,632	11,777	12,009
Gross Profit	11,338	11,312	11,223	9,706	8,772	8,671
Selling, General & Admin	6,523	6,563	6,168	5,827	5,327	5,084
Research & Development	1,530	1,471	1,462	966.86	810.47	767.55
Other Operating Expenses	143.37	140.36	202.61	205.86	224.56	143.78
Operating Expenses	8,320	8,299	7,904	7,057	6,411	6,015
Operating Income	3,018	3,014	3,319	2,649	2,361	2,656
Interest Expense	-347.09	-351.37	-354.14	-476.57	-602.15	-833.6
Interest & Investment Income	190.23	185.18	265.56	978.8	365.38	376.23
Currency Exchange Gain (Loss)	-23.2	-23.2	45.96	123.67	-58.34	-100.37
Other Non Operating Income (Expenses)	-160.06	-186.88	-130.81	120.33	-59.2	-169.14
EBT Excluding Unusual Items	2,678	2,637	3,146	3,395	2,007	1,929
Impairment of Goodwill	-206.98	-206.98	-26.15	-35.33	-42.68	-49.94
Gain (Loss) on Sale of Investments	55.77	50.08	136.85	43.42	7.89	16.4
Gain (Loss) on Sale of Assets	-15.32	-16.29	-4.14	-51.51	26.06	-3.35
Asset Writedown	-103.86	-104.2	-24.72	-36.4	-7.17	-4.72
Other Unusual Items	33.4	62.91	156.13	110.86	182.16	139.58
Pretax Income	2,441	2,423	3,384	3,426	2,173	2,027
Income Tax Expense	611.98	644.49	568.56	354.75	354.78	385.14
Earnings From Continuing Operations	1,829	1,778	2,815	3,071	1,818	1,642
Minority Interest in Earnings	-445.07	-448.6	-680.78	-587.19	-501.05	-636.46
Net Income	1,384	1,330	2,134	2,484	1,317	1,006
Net Income to Common	1,384	1,330	2,134	2,484	1,317	1,006
Net Income Growth	-29.24%	-37.70%	-14.07%	88.60%	30.96%	19.37%
Shares Outstanding (Basic)	1,626	1,622	1,617	1,613	1,587	1,378
Shares Outstanding (Diluted)	1,626	1,622	1,629	1,613	1,606	1,378
Shares Change (YoY)	-0.21%	-0.47%	1.01%	0.42%	16.59%	-5.16%
EPS (Basic)	0.85	0.82	1.32	1.54	0.83	0.73
EPS (Diluted)	0.85	0.82	1.31	1.54	0.82	0.73
EPS Growth	-29.10%	-37.41%	-14.94%	87.81%	12.33%	25.86%
Free Cash Flow	1,059	1,143	8.93	-672.27	475.78	991.85
Free Cash Flow Per Share	0.65	0.70	0.01	-0.42	0.30	0.72
Dividend Per Share	0.470	0.470	0.460	0.160	0.150	0.100
Dividend Growth	2.17%	2.17%	187.50%	6.67%	50.00%	100.00%
Gross Margin	44.98%	44.47%	45.76%	43.45%	42.69%	41.93%
Operating Margin	11.97%	11.85%	13.53%	11.86%	11.49%	12.84%
Profit Margin	5.49%	5.23%	8.70%	11.12%	6.41%	4.86%
Free Cash Flow Margin	4.20%	4.50%	0.04%	-3.01%	2.31%	4.80%
EBITDA	3,898	3,876	4,108	3,372	3,020	3,337
EBITDA Margin	15.47%	15.24%	16.75%	15.10%	14.70%	16.14%
D&A For EBITDA	880.55	862.19	788.75	723.08	659.23	680.67
EBIT	3,018	3,014	3,319	2,649	2,361	2,656
EBIT Margin	11.97%	11.85%	13.53%	11.86%	11.49%	12.84%
Effective Tax Rate	25.07%	26.60%	16.80%	10.35%	16.33%	19.00%
Revenue as Reported	25,206	25,435	24,525	22,338	20,549	20,680

Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.